A ruling against Trump would set the stage for potential legal fights over refunds in tariffs paid by importers. Over 1,000 companies are already lined up in court.
Industry insiders say any rise in duties on Indian generics will squeeze profits for Indian companies, but will also make the drugs costlier for patients in US.
The strategic drift currently being witnessed runs the risk of confirming the doubters’ view lurking on both sides: that the US is an unreliable power, and India is a reluctant partner.
With recruitments under Agnipath set to rise, the Union Budget has significantly increased spending, with the Army taking nearly 87% of the total outlay.
The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.
COMMENTS